Challenges:
Organ transplantation faces a critical shortage of donor organs, necessitating innovative solutions to meet the high demand. Joshi highlighted the potential of 3D bioprinting to address this gap by developing bio-printed tissues that can function as supplements, repairs, or eventual replacements for damaged organs.
Objectives of the Clinical Intervention:
To develop functional 3D bio-printed tissues that mimic the function and structure of native tissues while ensuring they can be utilized post-transplantation for therapeutic applications, including tissue repair, augmentation, and, ultimately, organ replacement.
Approaches and Actions Taken:
- Cellular Inputs: Primary differentiated cells, isolated from cadaveric donor organs, are used to create bio-ink.
- Bioprinting Process: Advanced bioprinting techniques deposit multiple cell types in precise geometries, creating complex, cell-dense tissues that recapitulate key features of native tissues.
- Functional Validation: Tissues are assessed for functional endpoints, such as liver-specific
protein production and viability assays to confirm tissue health.
Organovo’s focus has been on developing liver tissues, given their complex cellular composition and significant demand. The bioprinting process involves mixing primary liver cells in precise physiologically relevant ratios with excipient hydrogels to create a bio-ink,
which is then used to print tissues with high precision and reproducibility.
Data and Results:
- Implantation and Engraftment: Bio-printed liver patches were successfully implanted in mouse models, showing good retention, structural integrity, and functional performance, with vascularization evident by day 28.
- Disease Model Testing: In transgenic mouse models of Alpha-1 Antitrypsin Deficiency, bio-printed patches reduced misfolded protein accumulation in the liver, and indicating therapeutic benefits and improved liver function.
- Scaling and Viability: Challenges include sourcing large cell quantities and maintaining viability during the printing process.
Future Directions and Challenges:
- Cell Sourcing: The need for large quantities of high-quality cells to create larger tissues.
- Tissue Viability: Maintaining cell viability and function during the bioprinting and maturation processes when subjected to harsh conditions.
- Vascularization: Adequate vascularization of printed tissues to support their survival and
integration post-implantation.
Conclusion:
Joshi concluded by highlighting the substantial advancements in 3D bioprinting technology and its potential to address the organ shortage crisis. Developing full-size, transplantable organs remains a long-term goal, but the current focus is on developing tissues that
could serve as a bridge to transplant. Despite existing challenges, continued research and collaboration within the scientific community is vital to harness the full potential of 3D bioprinted tissues in clinical settings.
